Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers (original) (raw)
References
Agathanggelou A, Bieche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S, Gao B, Minna JD, Downward J, Maher ER and Latif F . (2003). Cancer Res., 63, 5344–5351.
Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N and Perucho M . (1988). Cell, 53, 549–554.
Arozarena I, Matallanas D, Berciano MT, Sanz-Moreno V, Calvo F, Munoz MT, Egea G, Lafarga M and Crespo P . (2004). Mol. Cell. Biol., 24, 1516–1530.
Asada K, Miyamoto K, Fukutomi T, Tsuda H, Yagi Y, Wakazono K, Oishi S, Fukui H, Sugimura T and Ushijima T . (2003). Oncology, 64, 380–388.
Bardeesy N and DePinho RA . (2002). Nat. Rev. Cancer, 2, 897–909.
Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE . (1994). Nat. Genet., 8, 27–32.
Clark TG, Conway SJ, Scott IC, Labosky PA, Winnier G, Bundy J, Hogan BL and Greenspan DS . (1999). Development, 126, 2631–2642.
Costa FF, Verbisck NV, Salim AC, Ierardi DF, Pires LC, Sasahara RM, Sogayar MC, Zanata SM, Mackay A, O'Hare M, Soares F, Simpson AJ and Camargo AA . (2004). Oncogene, 23, 1481–1488.
Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA and Tsao MS . (1996). Am. J. Pathol., 148, 1763–1770.
Griffin CA, Hruban RH, Long PP, Morsberger LA, Douna-Issa F and Yeo CJ . (1994). Genes Chromosomes Cancer, 9, 93–100.
Hahn SA, Schutte M, Hoque AT, Moskaluk CA, Da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH and Kern SE . (1996). Science, 271, 350–353.
Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB . (1995). Cancer Res., 55, 4525–4530.
Horikoshi N, Cong J, Kley N and Shenk T . (1999). Biochem. Biophys. Res. Commun., 261, 864–869.
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ . (2003). CA Cancer J. Clin., 53, 5–26.
Julien JP and Mushynski WE . (1998). Prog. Nucleic Acid Res. Mol. Biol., 61, 1–23.
Kaneda A, Kaminishi M, Yanagihara K, Sugimura T and Ushijima T . (2002). Cancer Res., 62, 6645–6650.
Kaneda A, Takai D, Kaminishi M, Okochi E and Ushijima T . (2003). Ann. NY Acad. Sci., 983, 131–141.
Lisitsyn N and Wigler M . (1993). Science, 259, 946–951.
Liu N, Furukawa T, Kobari M and Tsao MS . (1998). Am. J. Pathol., 153, 263–269.
Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D . (1995). Nat. Med., 1, 686–692.
Mitchell MS, Kan-Mitchell J, Minev B, Edman C and Deans RJ . (2000). Cancer Res., 60, 6448–6456.
Miyamoto K, Asada K, Fukutomi T, Okochi E, Yagi Y, Hasegawa T, Asahara T, Sugimura T and Ushijima T . (2003). Oncogene, 22, 274–280.
Omeis IA, Hsu YC and Perin MS . (1996). Genomics, 36, 543–545.
Qiu C, Yu M, Shan L and Snyderwine EG . (2003). Oncogene, 22, 1253–1260.
Riley P, Anson-Cartwright L and Cross JC . (1998). Nat. Genet., 18, 271–275.
Rozenblum E, Schutte M, Goggins M, Hahn SA, Panzer S, Zahurak M, Goodman SN, Sohn TA, Hruban RH, Yeo CJ and Kern SE . (1997). Cancer Res., 57, 1731–1734.
Sato N, Fukushima N, Maitra A, Matsubayashi H, Yeo CJ, Cameron JL, Hruban RH and Goggins M . (2003). Cancer Res., 63, 3735–3742.
Takai D and Jones PA . (2002). Proc. Natl. Acad. Sci. USA, 99, 3740–3745.
Takai D, Yagi Y, Wakazono K, Ohishi N, Morita Y, Sugimura T and Ushijima T . (2001). Oncogene, 20, 7505–7513.
Tourtellotte WG, Nagarajan R, Auyeung A, Mueller C and Milbrandt J . (1999). Development, 126, 5061–5071.
Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB and Issa JP . (1999). Cancer Res., 59, 2307–2312.
Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, Hruban RH and Goggins M . (2001). Cancer Res., 61, 8540–8546.
Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH and Goggins M . (2000). Cancer Res., 60, 1835–1839.
Ushijima T, Morimura K, Hosoya Y, Okonogi H, Tatematsu M, Sugimura T and Nagao M . (1997). Proc. Natl. Acad. Sci. USA, 94, 2284–2289.
Wilentz RE, Iacobuzio-Donahue CA, Argani P, McCarthy DM, Parsons JL, Yeo CJ, Kern SE and Hruban RH . (2000). Cancer Res., 60, 2002–2006.